Loading clinical trials...
Loading clinical trials...
Comparative Analysis of Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion
Conditions
Interventions
Conduit Titanium Interbody Graft
Concorde Bullet Device
Locations
1
United States
Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
Start Date
March 12, 2021
Primary Completion Date
December 31, 2023
Completion Date
March 31, 2024
Last Updated
July 3, 2024
NCT05029726
NCT04140344
NCT03439228
NCT04418830
NCT06000319
NCT03853356
Lead Sponsor
Lahey Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions